Cystic Fibrosis in South Africa By Dr Someshni Moodley 29 May 2023 Currently, there are less than 600 diagnosed cases of Cystic Fibrosis (CF) in South Africa, but experts believe that this number represents only a fraction of the actual cases.
Use of autologous ADSCs for ovarian rejuvenation By Dr Yvonne Holt 22 May 2023 Advances in adult stem cell research and their clinical application prompted interest in their use in assisted reproduction.
The loss of a life unlived: Why do miscarriages happen? By Mandy Rodrigues 16 May 2023 After losing a pregnancy, there are many unanswered questions. As humans, we may want answers because that helps us navigate the future with more certainty.
Benefits of Non-Invasive Prenatal Testing (NIPT) By Ashleigh Bouguenon 12 April 2023 NIPT has increasingly become part of routine prenatal screening due to its many benefits.
Translational use of Wharton’s jelly In repairing cleft lip and palate By Next Biosciences 31 July 2017 Explore the potential of Wharton's jelly in the repair of cleft palates, and how it could revolutionise current surgical approaches.
Genetic testing of Products of Conception (POCs) By Jaysen Knezovich 23 March 2017 Chromosomal aneuploidies are the most common cause of first-trimester miscarriage, accounting for approximately 50% of spontaneous abortions.
A case for newborn screening in South Africa By Next Biosciences 22 March 2017 Newborn screening is a worldwide recognised public health measure aimed at the early screening, diagnosis and management of selected metabolic diseases.
A healthy pregnancy starts with a healthy embryo By Jaysen Knezovich 10 March 2017 Discover how pre-implantation genetic screening can reduce the risk of miscarriage and genetic conditions during IVF.
Dry eye decision tree – 10 years after DEWS By Jason Schmit, OD 21 February 2017 The first step in developing the most appropriate treatment plan for a patient with dry eye disease (DED) is to correctly categorise the stage and type of DED the patient exhibits using the available technology. Then address the patient’s symptoms using the appropriate evidence-based therapies.
Stem cell revolution By Next Biosciences 18 January 2017 We are at the cusp of a stem cell revolution. Understanding and harnessing these unique cells may unlock breakthroughs in longevity and therapeutic solutions to all kinds of chronic diseases and regenerative opportunities.
Stem cell storage: Invest in your family’s future health By Dr Nick Walker 11 January 2017 Stem cells are a type of cell that holds the potential to differentiate into different cell types and self-renew. The interest in stem cells in the medical field is at an all-time high.
Introducing FirstScreen: The revolutionary newborn screening test By Next Biosciences 01 December 2016 Next Biosciences’ role in developing FirstScreen with North-West University is to establish a newborn screening programme that is widely accessible to South African doctors and patients.
Biological reasons for the discordance of Monosomy X By Next Biosciences 01 December 2016 While a considerable amount of data exists for clinical trials and laboratory performance for non-invasive prenatal testing (NIPT) of autosomal aneuploidies (chromosomal abnormalities), relatively little data is available on laboratory performance for sex chromosome aneuploidies.
Co-transplantation of umbilical cord tissue MSCs By Next Biosciences 01 December 2016 Exciting clinical work continues in transplant medicine and mesenchymal stem cell therapy. Recent studies from China highlight the co-transplantation of umbilical cord mesenchymal stem cells (UC-MSC) and umbilical cord blood haematopoietic stem cells (CB-HSC).
What you don’t know about newborn screening By Next Biosciences 13 October 2016 Act now to give your baby the best chance for a healthy future. Learn about newborn screening and how it can detect serious conditions early on.
Next Biosciences' partners with Adcock Ingram By Next Biosciences 16 August 2023 Next Biosciences is thrilled to unveil its strategic partnership with Adcock Ingram as of July 2023, a renowned leader in the eye care field.
Dry eye decision tree – 10 years after DEWS By Jason Schmit, OD 21 February 2017 The first step in developing the most appropriate treatment plan for a patient with dry eye disease (DED) is to correctly categorise the stage and type of DED the patient exhibits using the available technology. Then address the patient’s symptoms using the appropriate evidence-based therapies.
Biological reasons for the discordance of Monosomy X By Next Biosciences 01 December 2016 While a considerable amount of data exists for clinical trials and laboratory performance for non-invasive prenatal testing (NIPT) of autosomal aneuploidies (chromosomal abnormalities), relatively little data is available on laboratory performance for sex chromosome aneuploidies.
Innovative wound-healing technique using amniotic membrane By Next Biosciences 13 July 2016 According to a recent article in Live Science, human amniotic membrane biological patches can be used to treat superficial wounds such as partial thickness burn wounds, diabetic foot ulcers, venous leg ulcers and bed sores.
Application of umbilical cord serum eyedrops for dry eye syndrome By Next Biosciences 04 November 2015 Umbilical cord serum contains essential tear components, and umbilical cord serum eyedrops are effective and safe for treating severe dry eye syndrome.
Application of umbilical cord serum eyedrops for Neurotrophic Keratitis By Next Biosciences 04 November 2015 Application of umbilical cord serum eyedrops for the treatment of Neurotrophic Keratitis
Comparison of autologous serum and umbilical cord serum eye drops By Next Biosciences 04 November 2015 To compare the therapeutic effect between autologous serum and umbilical cord serum eye drops in treating severe dry eye syndrome.
Amniotic membrane transplantation By Next Biosciences 30 October 2015 Amniotic membrane transplantation may be considered an alternative method for treating persistent epithelial defects and sterile ulceration that are refractory to conventional treatment and before considering treatment by conjunctival flaps or tarsorrhaphy.
World Cord Blood Day: Understanding cord blood stem cells By Dr Someshni Moodley 15 November 2023 As we celebrate World Cord Blood Day, it is an opportune moment to explore the incredible value held within a simple resource: umbilical cord blood. Amidst the wonder of welcoming a newborn into the world, parents are often unaware of the lifesaving potential contained within cord blood, which are stem cells.
The truth about placental tissue storage: Is it worth it? By Dr Someshni Moodley 14 November 2023 Discover the truth about placental tissue storage. Are the benefits worth the cost? Unveiling the facts for informed family decisions.
Delayed cord clamping By Dr Someshni Moodley 29 May 2023 After the delivery of a baby, the umbilical cord is traditionally clamped and cut. However, delayed cord clamping (DCC) allows for some of the blood in the cord and placenta to flow back to the baby.
Cystic Fibrosis in South Africa By Dr Someshni Moodley 29 May 2023 Currently, there are less than 600 diagnosed cases of Cystic Fibrosis (CF) in South Africa, but experts believe that this number represents only a fraction of the actual cases.
Use of autologous ADSCs for ovarian rejuvenation By Dr Yvonne Holt 22 May 2023 Advances in adult stem cell research and their clinical application prompted interest in their use in assisted reproduction.
Translational use of Wharton’s jelly In repairing cleft lip and palate By Next Biosciences 31 July 2017 Explore the potential of Wharton's jelly in the repair of cleft palates, and how it could revolutionise current surgical approaches.
Stem cell revolution By Next Biosciences 18 January 2017 We are at the cusp of a stem cell revolution. Understanding and harnessing these unique cells may unlock breakthroughs in longevity and therapeutic solutions to all kinds of chronic diseases and regenerative opportunities.
Stem cell storage: Invest in your family’s future health By Dr Nick Walker 11 January 2017 Stem cells are a type of cell that holds the potential to differentiate into different cell types and self-renew. The interest in stem cells in the medical field is at an all-time high.
Introducing ‘Families of Hope’ from Netcells By Next Biosciences 05 September 2016 We started discussing the form our corporate social investment would take well over a year ago.
Brain injury stem cell therapy advances By Dr Michelle Mason 20 July 2016 There enormous growth in perinatal stem cell research, particularly the non-haematological uses of both cord blood and cord tissue stem cells.
A second Netcells baby heads to the US for stem cell treatment By Next Biosciences 12 July 2016 Our Netcells team is proud to announce that we have released a second unit of umbilical cord blood belonging to a three-year-old Netcells baby born with cerebral palsy.
July is Cord Blood Awareness Month By Next Biosciences 07 July 2016 Expectant parents are faced with a number of decisions before the birth of a baby, among them whether to collect the baby’s umbilical cord blood at birth.
Next Biosciences’ donation to CHOC By Next Biosciences 16 April 2016 Next Biosciences will work closely with CHOC to ensure that any unutilised funds from procedural fees donated by obstetricians will be directed to CHOC, as the Netcells ‘Families of Hope’ programme’s goals are closely aligned to theirs: Keeping more than hope alive.
Next Biosciences’ Dr Nick Walker is off to Silicon Valley By Next Biosciences 11 April 2016 Winner of first South African Global Impact Competition presents an innovative concept to address HIV/AIDS.
Sibling Cord Blood Therapy for Cerebral Palsy By Dr Yvonne Holt 24 March 2016 Children with cerebral palsy can now be treated with sibling cord blood therapy.
Next Biosciences is just here for the sex with MiniMi By Next Biosciences 04 December 2023 Next Biosciences' Laboratory Research and Technical Specialist, Gloudi Agenbag has developed the MiniMi Early Fetal Sex Test that allows expecting parents the choice to find out their baby’s sex from as early as 10 weeks, with an accuracy of 98%.
Updated position statement from the ISPD By Next Biosciences 13 November 2023 The International Society for Prenatal Diagnosis have recently published a position statement in Prenatal Diagnosis on the use of non-invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies.
Newborn Screening: Genetic and metabolic disease diagnoses in South Africa By Next Biosciences 21 September 2023 In this blog post, we will delve into the landscape of genetic and metabolic disease diagnoses in South Africa, highlighting key conditions, prevalence rates, and the role of ethnicity in susceptibility.
Importance of a universal newborn screening in South Africa By Next Biosciences 18 August 2023 Newborn screening is a remarkable tool that empowers healthcare professionals to identify potential threats before they can impact a new baby’s health.
Global NIPT consortium members By Ashleigh Bouguenon 12 June 2023 Non-invasive prenatal testing (NIPT) is a prenatal screening method that provide information about the risk of chromosome abnormalities by analysing placental DNA that is circulating in a pregnant woman’s blood.
Use of autologous ADSCs for ovarian rejuvenation By Dr Yvonne Holt 22 May 2023 Advances in adult stem cell research and their clinical application prompted interest in their use in assisted reproduction.
The loss of a life unlived: Why do miscarriages happen? By Mandy Rodrigues 16 May 2023 After losing a pregnancy, there are many unanswered questions. As humans, we may want answers because that helps us navigate the future with more certainty.
Benefits of Non-Invasive Prenatal Testing (NIPT) By Ashleigh Bouguenon 12 April 2023 NIPT has increasingly become part of routine prenatal screening due to its many benefits.
Genetic testing of Products of Conception (POCs) By Jaysen Knezovich 23 March 2017 Chromosomal aneuploidies are the most common cause of first-trimester miscarriage, accounting for approximately 50% of spontaneous abortions.
A case for newborn screening in South Africa By Next Biosciences 22 March 2017 Newborn screening is a worldwide recognised public health measure aimed at the early screening, diagnosis and management of selected metabolic diseases.
A healthy pregnancy starts with a healthy embryo By Jaysen Knezovich 10 March 2017 Discover how pre-implantation genetic screening can reduce the risk of miscarriage and genetic conditions during IVF.
Introducing FirstScreen: The revolutionary newborn screening test By Next Biosciences 01 December 2016 Next Biosciences’ role in developing FirstScreen with North-West University is to establish a newborn screening programme that is widely accessible to South African doctors and patients.
Co-transplantation of umbilical cord tissue MSCs By Next Biosciences 01 December 2016 Exciting clinical work continues in transplant medicine and mesenchymal stem cell therapy. Recent studies from China highlight the co-transplantation of umbilical cord mesenchymal stem cells (UC-MSC) and umbilical cord blood haematopoietic stem cells (CB-HSC).
What you don’t know about newborn screening By Next Biosciences 13 October 2016 Act now to give your baby the best chance for a healthy future. Learn about newborn screening and how it can detect serious conditions early on.
HLA matching embryos for the potential treatment of life-threatening conditions By Jaysen Knezovich 20 July 2016 Current academic views on cord blood banking are still conservative as the lifetime likelihood of developing a blood-related disease requiring transplantation remains low.
Next Biosciences and Genesis, Genetics South Africa combine their DNA By Next Biosciences 20 May 2016 The merger of local leaders in stem cell banking and genetic testing consolidates their position in the African biotechnology industry.
Next Biosciences offers FirstScreen By 20 April 2016 A newborn screening test is done in collaboration with North-West University and includes tests relevant to the South African population.
Next Biosciences launches PharmaGene By Next Biosciences 24 October 2023 Next Biosciences is changing the face of medicine in the country with the launch of PharmaGene – a new pharmacogenomics test, making individualised precision medicine possible.
The food-mood connection: How dietary choices affect mood swings By Next Biosciences 09 October 2023 Research has shed light on the intricate relationship between our diets, the gut microbiome, and mood regulation. The blog post delves into the fascinating connection between dietary habits and mood swings and how you can make informed choices to support your mental health.
Enabling a more personalised approach to psychiatric treatment By Caela De Beer 03 October 2023 Psychiatry has come a long way in its understanding and treatment of mental health disorders. Gone are the days of a one-size-fits-all approach to psychiatric medication.
The benefits of a healthy gut By Next Biosciences 07 August 2023 Gut disturbances can negatively affect various aspects of your well-being, including your immune system, your skin, sleep patterns, and so much more. Here are some of the benefits of a healthy gut.
Viome Gut Microbiome Test: The power of personalised nutrition By Next Biosciences 27 July 2023 By analysing the unique composition of our gut bacteria, personalised nutrition empowers us to make informed dietary choices that cater to our specific needs, optimising nutrient absorption, energy levels, and performance.
Unlocking your genetic potential with 3X4 Genetics By Next Biosciences 27 July 2023 Within the intricate helix of your DNA lies a wealth of knowledge about your body's unique characteristics and responses. From how you react to different forms of exercise to your susceptibility to specific health conditions and even your nutritional requirements, your genetic makeup holds the key to optimising your well-being.
Next Biosciences' partners with Adcock Ingram By Next Biosciences 16 August 2023 Next Biosciences is thrilled to unveil its strategic partnership with Adcock Ingram as of July 2023, a renowned leader in the eye care field.
Use of autologous ADSCs for ovarian rejuvenation By Dr Yvonne Holt 22 May 2023 Advances in adult stem cell research and their clinical application prompted interest in their use in assisted reproduction.
Next Biosciences partners with save the cord foundation By Charis Ober 10 February 2016 Cord blood stem cells are currently being used to treat 80+ diseases, including many blood cancers like leukaemia and lymphoma.
Second autologous transplant for aplastic anaemia successful By Dr Michelle Mason 29 January 2016 Second autologous transplant for aplastic anaemia successful